Christopher P. Filson

2.2k total citations · 1 hit paper
86 papers, 1.4k citations indexed

About

Christopher P. Filson is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Christopher P. Filson has authored 86 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 27 papers in Surgery and 19 papers in Economics and Econometrics. Recurrent topics in Christopher P. Filson's work include Prostate Cancer Diagnosis and Treatment (31 papers), Bladder and Urothelial Cancer Treatments (24 papers) and Prostate Cancer Treatment and Research (23 papers). Christopher P. Filson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (31 papers), Bladder and Urothelial Cancer Treatments (24 papers) and Prostate Cancer Treatment and Research (23 papers). Christopher P. Filson collaborates with scholars based in United States, Canada and South Africa. Christopher P. Filson's co-authors include Leonard S. Marks, Mark S. Litwin, Hung‐Jui Tan, Patricia Lieu, Daniel Margolis, Frederick J. Dorey, Jiaoti Huang, Shyam Natarajan, Robert E. Reiter and Lorna Kwan and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Christopher P. Filson

75 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: The role of systematic and targeted biopsies

2016 305 citations Christopher P. Filson et al. Cancer profile →

Peers

Christopher P. Filson

PRM

SURGE

ONCOL

RHEUM

EPIDE

Ronald Kodama Canada

Sophie Knipper Germany

L. Cormier France

Declan Cahill United Kingdom

Paweł Rajwa Poland

Rodolphe Thuret France

Nora Ruel United States

Erin Kirkby United States

Gustavo Franco Carvalhal Brazil

Sanoj Punnen United States

Ronald Kodama Canada

Christopher P. Filson

661 ×0.7

PRM

279 ×0.7

SURGE

189 ×0.6

ONCOL

154 ×0.6

RHEUM

100 ×0.5

EPIDE

Citations per year, relative to Christopher P. Filson Christopher P. Filson (= 1×) peers Ronald Kodama

Countries citing papers authored by Christopher P. Filson

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Filson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Filson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Filson more than expected).

Fields of papers citing papers by Christopher P. Filson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Filson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Filson. The network helps show where Christopher P. Filson may publish in the future.

Co-authorship network of co-authors of Christopher P. Filson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Filson. A scholar is included among the top collaborators of Christopher P. Filson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Filson. Christopher P. Filson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Das, Arighno, Glenn O. Allen, Soroush Rais‐Bahrami, et al.. (2025). Prostate zonal impact of 5α‐reductase inhibitors on multiparametric MRI characteristics and detection of prostate cancer. British Journal of Urology. 137(2). 332–338.

Newcomb, Lisa F., Jeannette M. Schenk, Yingye Zheng, et al.. (2024). Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. JAMA. 331(24). 2084–2084. 22 indexed citations

Horný, Michal, K. Robin Yabroff, Christopher P. Filson, et al.. (2023). The cost burden of metastatic prostate cancer in the US populations covered by employer‐sponsored health insurance. Cancer. 129(20). 3252–3262. 3 indexed citations

Janopaul‐Naylor, James, Jeffrey M. Switchenko, Sheela Hanasoge, et al.. (2023). Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act. Cancer Medicine. 12(17). 18258–18268. 5 indexed citations

Fang, Andrew M., Kimberly D. Martin, Richard E. Fan, et al.. (2022). Multi‐institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI‐RADS 3 lesions. Cancer. 128(18). 3287–3296. 21 indexed citations

Fischer‐Valuck, Benjamin W., Brian C. Baumann, Simon Brown, et al.. (2022). Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer. European Urology Open Science. 37. 80–89. 4 indexed citations

Patil, Dattatraya, Vikram M. Narayan, Viraj A. Master, et al.. (2021). Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders. Cancer Medicine. 10(23). 8412–8420. 9 indexed citations

Zhu, Kehao, Yingye Zheng, Lisa F. Newcomb, et al.. (2021). Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. Cancer. 128(2). 269–274. 5 indexed citations

Patil, Dattatraya, et al.. (2021). Palliative care use among bladder cancer patients treated with radical cystectomy. Urologic Oncology Seminars and Original Investigations. 39(11). 788.e1–788.e6. 1 indexed citations

10.

Patil, Dattatraya, et al.. (2020). Contemporary Patterns of Third-line Treatments for Privately Insured Individuals With Overactive Bladder in the United States. Urology. 142. 87–93. 5 indexed citations

11.

Fischer‐Valuck, Benjamin W., Yuan James Rao, Randall Brenneman, et al.. (2020). Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer. Brachytherapy. 19(5). 557–566. 2 indexed citations

12.

Filson, Christopher P., et al.. (2020). In-Bore MRI-guided Prostate Biopsies in Patients with Prior Positive Transrectal US–guided Biopsy Results: Pathologic Outcomes and Predictors of Missed Cancers. Radiology Imaging Cancer. 2(5). e190078–e190078. 8 indexed citations

13.

Filson, Christopher P., John M. Hollingsworth, Chang He, et al.. (2016). Patient-Reported Convalescence and Quality of Life Recovery. Surgical Innovation. 23(6). 598–605. 10 indexed citations

14.

Filson, Christopher P., Hung‐Jui Tan, Karim Chamie, Aaron A. Laviana, & Jim C. Hu. (2016). Determinants of radical cystectomy operative time. Urologic Oncology Seminars and Original Investigations. 34(10). 431.e17–431.e24. 12 indexed citations

15.

Tan, Hung‐Jui, Timothy J. Daskivich, Joseph D. Shirk, et al.. (2016). Health status and use of partial nephrectomy in older adults with early-stage kidney cancer. Urologic Oncology Seminars and Original Investigations. 35(4). 153.e7–153.e14. 10 indexed citations

16.

Banerjee, Mousumi, Christopher P. Filson, Rong Xia, & David C. Miller. (2014). Logic Regression for Provider Effects on Kidney Cancer Treatment Delivery. Computational and Mathematical Methods in Medicine. 2014. 1–9. 2 indexed citations

17.

Filson, Christopher P., et al.. (2014). Improvement in Clinical TNM Staging Documentation Within a Prostate Cancer Quality Improvement Collaborative. Urology. 83(4). 781–787. 17 indexed citations

18.

Tan, Hung‐Jui, Christopher P. Filson, & Mark S. Litwin. (2014). Contemporary, age-based trends in the incidence and management of patients with early-stage kidney cancer. Urologic Oncology Seminars and Original Investigations. 33(1). 21.e19–21.e26. 22 indexed citations

19.

Filson, Christopher P., Bruce G. Redman, Rodney L. Dunn, & David C. Miller. (2011). Initial Patterns of Care With Oral Targeted Therapies for Patients With Renal Cell Carcinoma. Urology. 77(4). 825–830.e1. 17 indexed citations

20.

Filson, Christopher P., John M. Hollingsworth, Ted A. Skolarus, J. Quentin Clemens, & Brent K. Hollenbeck. (2010). Health care reform in 2010: transforming the delivery system to improve quality of care. World Journal of Urology. 29(1). 85–90. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact